Instead, LGALS3 is mostly used as a biomarker for thyroid cancer diagnosis, and given its participation in tumor progression, it is currently under investigation as a potential target for thyroid cancer treatment [77]. This evidence concerns the gene LGALS3 and thyroid cancer.